Baxter Phillips

Baxter Phillips

Geschäftsführer bei LOBE SCIENCES LTD.

Vermögen: 11 560 $ am 31.05.2024

48 Jahre
Health Technology
Consumer Services
Process Industries

Ursprung des Netzwerks ersten Grades von Baxter Phillips

EinheitArt der EinheitIndustrie
Extinct Pharmaceuticals: Other 9
Public Company Agricultural Commodities/Milling 8
8
Extinct Biotechnology 8
4
Holding Company Pharmaceuticals: Major 4
1
Holding Company Biotechnology 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Baxter Phillips

UnternehmenSektorVerknüpfte PersonenHauptposition
Medical Specialties

Enda Kenny

Corporate Officer/Principal

ONCOTELIC THERAPEUTICS, INC. Biotechnology

Bobby Sandage

Matthew M. Loar

Director/Board Member

Director of Finance/CFO

Miscellaneous Commercial Services

Thadd M. Vargas

Brian Zasitko

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Christian Hansen

Florian Schönharting

John M. Barberich

Private Equity Investor

Chief Executive Officer

Private Equity Investor

SOL GLOBAL INVESTMENTS CORP. Miscellaneous Commercial Services

Jonathan Gilbert

Maghsoud Dariani

Michael Petter

Chief Executive Officer

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

Jonathan Gilbert

Michael Petter

Chief Executive Officer

Founder

Miscellaneous Commercial Services

Philip Young

Frederick Sancilio

Chief Executive Officer

Founder

Biotechnology

Jeremy Curnock-Cook

Enda Kenny

Director/Board Member

Director/Board Member

FORWARD PHARMA A/S Pharmaceuticals: Major

Christian Hansen

Florian Schönharting

Director/Board Member

Founder

Trinity College Dublin College/University

Jeremy Curnock-Cook

David O'Flynn

Graduate Degree

Undergraduate Degree

ACADIA PHARMACEUTICALS INC. Pharmaceuticals: Major

Florian Schönharting

John M. Barberich

Founder

Director of Finance/CFO

University College Dublin College/University

Enda Kenny

Undergraduate Degree

Investment Managers

Jonathan Milner

Director/Board Member

Biotechnology

Jonathan Milner

Director/Board Member

Meltwind Advisory LLP

Jonathan Milner

Corporate Officer/Principal

Financial Conglomerates

Jonathan Milner

Director/Board Member

Syndicate Room Group Ltd.

Jonathan Milner

Director/Board Member

Miscellaneous Commercial Services

Jonathan Milner

Chairman

Financial Conglomerates

Jonathan Milner

Director/Board Member

Investment Managers

Jonathan Milner

Consultant / Advisor

Financial Conglomerates

Jonathan Milner

Director/Board Member

Imperial College London College/University

Enda Kenny

Doctorate Degree

GENMAB A/S Pharmaceuticals: Major

Florian Schönharting

Founder

Investment Managers

Julian P. Kirk

Chief Executive Officer

Miscellaneous Commercial Services

Florian Schönharting

Chairman

Financial Conglomerates

Florian Schönharting

Corporate Officer/Principal

ZEALAND PHARMA A/S Pharmaceuticals: Major

Florian Schönharting

Founder

Life Cycle Pharma A/S

Florian Schönharting

Founder

Danish Corporate Governance Association

Florian Schönharting

Director/Board Member

Copenhagen Business School College/University

Florian Schönharting

Graduate Degree

Data Processing Services

Jonathan Milner

Director/Board Member

Pharmaceuticals: Other

Enda Kenny

Corporate Officer/Principal

Medical Specialties

Enda Kenny

General Counsel

Medical Specialties

Enda Kenny

Chief Operating Officer

Pharmaceuticals: Major

Jonathan Milner

Director/Board Member

AbShare Share Plan Ltd.

Jonathan Milner

Director/Board Member

HORIZON DISCOVERY GROUP PLC Medical Specialties

Jonathan Milner

Director/Board Member

Statistik

International

Vereinigtes Königreich 18
Vereinigte Staaten 11
Dänemark 10
Irland 5
Kanada 4

Sektoral

Health Technology 20
Finance 9
Commercial Services 8
Consumer Services 5
Technology Services 3

Operativ

Director/Board Member 166
Corporate Officer/Principal 60
Director of Finance/CFO 42
Chairman 41
Chief Executive Officer 40
  1. Börse
  2. Insiders
  3. Baxter Phillips
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT